Compared to amyloid PET, tau PET has been shown to predict cognitive decline in cognitively unimpaired individuals and is of high clinical relevance as assessment is associated with short-term progression (3 − 5 years) in these individuals [34, 35]. Here, MAPT is linked to Mental deterioration.